0 Комментарии
0 Поделились
3Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Clinical Next-Generation Sequencing Testing Market Advances Precision Medicine ApplicationsExecutive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share Forecast The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period By considering a definite base year...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Cancer Diagnostics Market to Reach USD 178.26 Billion by 2033, Driven by Rising Screening DemandMarket Overview The global cancer diagnostics market size was valued at USD 106.32 billion in 2024 and is projected to reach from USD 112.60 billion in 2025 to USD 178.26 billion by 2033, growing at a CAGR of 5.91% during the forecast period (2025-2033). The global Cancer Diagnostics market continues to evolve rapidly, driven by shifting consumer trends,...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Global Clinical NGS Testing Market Surges with Precision Medicine Growth and Faster Genetic DiagnosticsDetailed Analysis of Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period With this Clinical...0 Комментарии 0 Поделились 735 Просмотры 0 предпросмотр
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations in the...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How Is Tumor Markers Testing Market Improving Early Cancer Detection Accuracy?IntroductionThe tumor markers testing market focuses on diagnostic tests that detect specific substances produced by cancer cells or by the body in response to cancer. These substances, known as tumor markers, are found in blood, urine, or tissue samples. Tumor marker tests support cancer detection, diagnosis, prognosis, treatment monitoring, and recurrence assessment. Cancer remains...0 Комментарии 0 Поделились 957 Просмотры 0 предпросмотр
-
Why Is North America Leading Innovation in CTC Liquid Biopsy Technologies?"Executive Summary North America Circulating Tumor Cells (CTC) Liquid Biopsy Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the market is growing with a CAGR of 25.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,650.96 million by 2029 from USD 442.64 million in 2021. The key topics that have been described in this...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Why Is the Hereditary Cancer Testing Market Expanding in Preventive Healthcare?Executive Summary Hereditary Cancer Testing Market Research: Share and Size Intelligence CAGR Value Data Bridge Market Research analyzes that the global hereditary cancer testing market is expected to reach the value of USD 13,085.04 million by 2029, at a CAGR of 12.9% during the forecast period. This Hereditary Cancer Testing Market research report is a painstaking investigation of...0 Комментарии 0 Поделились 926 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek